Cannabis and work
With the legalization of recreational marijuana in Canada, workplaces are concerned about its implications for workplace health, safety and productivity. IWH researchers are watching the research literature and conducting their own studies in order to help answer questions about marijuana use at work: its scope, its effects, and its relationship to work-related injuries and deaths.
IWH in the media
Companies fret about hazy rules around pot use
Once recreational cannabis use becomes legal, taking a “smoke break” at work could suddenly become much more complicated, writes Cassandra Szklarski of the Canadian Press. The Institute for Work & Health's Dr. Andrea Furlan and Dr. Nancy Carnide are among those interviewed.
Published: National Post, December 2017
IWH in the media
Weed at work
The legalization of recreational marijuana in Canada came closer to reality on April 13, when the Justin Trudeau government introduced the Cannabis Act, or Bill C-45. While pot users across the country applaud the move, others have raised concerns about the effect that the proposed legislation would have on workplace safety, writes Jeff Cottrill in an article that quotes the Institute for Work & Health's Dr. Andrea Furlan.
Published: OHS Canada, August 2017
Project
Project
Central nervous system agents and the risk of workplace injury and death: a systematic review
IWH is leading a systematic review to determine the level and quality of research evidence on the association between workers’ use of agents that act on the central nervous system (e.g. opioids, cannabis) and the risk of workplace injury, reinjury, near misses and death, including outcomes affecting co-workers and others in the immediate workplace.
Status: Completed 2019